The Specific Endothelin A Receptor Antagonist ZD4054: Preclinical and Clinical Results

Research output: Contribution to conference (unpublished) › Paper

5 Citations (Scopus)

Original language	English
Pages	29-35
Number of pages	7
DOIs	https://doi.org/10.1016/j.eursup.2008.10.005
Publication status	Published - 1 Jan 2009
Event	23rd Annual Congress of the European-Association-of-Urology, Mar 26-29, 2008. Milan, Italy - Duration: 1 Jan 2009 → …

Conference	23rd Annual Congress of the European-Association-of-Urology, Mar 26-29, 2008. Milan, Italy
Period	1/01/09 → …

Keywords

This output contributes to the following UN Sustainable Development Goals (SDGs)

@conference{900b4766caf1492da5e03f08cee2ca29,

title = "The Specific Endothelin A Receptor Antagonist ZD4054: Preclinical and Clinical Results",

keywords = "Hormone-resistant prostate cancer, Endothelin A receptor antagonist, ZD4054, Phase 2",

author = "Nicholas James and JW Growcott",

year = "2009",

month = jan,

day = "1",

doi = "10.1016/j.eursup.2008.10.005",

language = "English",

pages = "29--35",

note = "23rd Annual Congress of the European-Association-of-Urology, Mar 26-29, 2008. Milan, Italy ; Conference date: 01-01-2009",

}

TY - CONF

T1 - The Specific Endothelin A Receptor Antagonist ZD4054: Preclinical and Clinical Results

AU - James, Nicholas

AU - Growcott, JW

PY - 2009/1/1

Y1 - 2009/1/1

KW - Hormone-resistant prostate cancer

KW - Endothelin A receptor antagonist

KW - ZD4054

KW - Phase 2

U2 - 10.1016/j.eursup.2008.10.005

DO - 10.1016/j.eursup.2008.10.005

M3 - Paper

SP - 29

EP - 35

T2 - 23rd Annual Congress of the European-Association-of-Urology, Mar 26-29, 2008. Milan, Italy

Y2 - 1 January 2009

ER -